Life Science Compliance Update



When Exaggeration Increases Compliance Risk – The Lessons of UHC and Inflated Risk Scores

Written by , Posted in Uncategorized

Janice G. Jacobs, CPA, CPC, CCS, CPCO, ROCC, Managing Director, Berkeley Research Group

Fraudulently exaggerating diagnosis coding is definitely on the government’s radar. This article explores the compliance risks associated with exaggerating diagnosis codes and ways to mitigate potential liability.


Menu Title